Ligand Pharmaceuticals
LGND
#3612
Rank
S$4.80 B
Marketcap
S$244.16
Share price
-1.57%
Change (1 day)
55.50%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): S$80.67 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are S$0.25 Billion. In 2024 the company made an earning of S$7.05 Million a decrease over its 2023 earnings that were of S$81.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$80.67 M1043.44%
2024 S$7.05 M-91.37%
2023 S$81.74 M-7.59%
2022 S$88.46 M4%
2021 S$85.06 M296.42%
2020 S$21.45 M-97.97%
2019 S$1.05 B275.62%
2018 S$0.28 B237.48%
2017 S$83.46 M49.05%
2016 S$55.99 M55.41%
2015 S$36.02 M36.87%
2014 S$26.32 M29.59%
2013 S$20.31 M1309.35%
2012 S$1.44 M-43.97%
2011 S$2.57 M-113.19%
2010 -S$19.51 Million59.86%
2009 -S$12.21 Million-61.33%
2008 -S$31.56 Million-58.75%
2007 -S$76.49 Million20.52%
2006 -S$63.47 Million81.27%
2005 -S$35.02 Million
2003 -S$24.38 Million-20.6%
2002 -S$30.7 Million4.38%
2001 -S$29.41 Million-48.83%
2000 -S$57.47 Million-19.74%
1999 -S$71.61 Million-19.06%
1998 -S$88.47 Million126.71%
1997 -S$39.03 Million-5.83%
1996 -S$41.44 Million136.23%
1995 -S$17.55 Million-33.97%
1994 -S$26.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.17 B 48,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.06 B 17,644.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$28.60 B 33,591.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$10.47 B 12,242.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-S$0.35 Billion-504.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$29.34 B 34,469.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.21 B 11,926.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$11.84 B 13,857.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-S$78.66 Million-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA